Literature DB >> 25750326

Validity of sentinel lymph node biopsy by ICG fluorescence for early head and neck cancer.

Takehiro Nakamura1, Yasunao Kogashiwa1, Hiroshi Nagafuji1, Koichi Yamauchi1, Naoyuki Kohno2.   

Abstract

AIM: This study was designed to assess the validity of sentinel lymph node (SLN) biopsy using either the combination of indocyanine green (ICG) fluorescence and radioisotope (RI) or ICG-alone in SLN mapping for early head and neck cancer patients. PATIENTS AND METHODS: Nineteen patients received SLN biopsy with the following method. Thirteen patients received SLN biopsy with only RI, 2 patients with only ICG and 4 patients with the combination of ICG and RI. Detection time for each method of SLN biopsy was measured to evaluate the validity of SLN with the combination of ICG and RI.
RESULTS: A total of 41 SLNs were identified by RI or ICG. All SLNs identified by ICG could be localized intraoperatively. The number of SLNs identified by the combination of ICG and RI was greater than that of SLNs identified by RI-alone. One of the patients who underwent SLN biopsy by RI-alone was diagnosed with a metastatic lymph node one year later, then underwent neck dissection. Mean detection time for SLN biopsy with ICG or with the combination of ICG and RI tended to be shorter than that of RI-alone.
CONCLUSION: SLN biopsy with the combination of ICG and RI enabled us to identify SLNs more easily and rapidly than by using RI alone. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  ICG fluorescence; Oral cancer; hypopharyngeal cancer; oropharyngeal cancer; radioisotope

Mesh:

Substances:

Year:  2015        PMID: 25750326

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

Review 1.  Diagnostic value of sentinel lymph node biopsy for cT1/T2N0 tongue squamous cell carcinoma: a meta-analysis.

Authors:  Yue Yang; Jian Zhou; Haitao Wu
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-12       Impact factor: 2.503

2.  Feasibility of Real-Time Near-Infrared Fluorescence Tracer Imaging in Sentinel Node Biopsy for Oral Cavity Cancer Patients.

Authors:  Anders Christensen; Karina Juhl; Birgitte Charabi; Jann Mortensen; Katalin Kiss; Andreas Kjær; Christian von Buchwald
Journal:  Ann Surg Oncol       Date:  2016-02       Impact factor: 5.344

3.  Feasibility of real-time near-infrared indocyanine green fluorescence endoscopy for the evaluation of mucosal head and neck lesions.

Authors:  Florian Schmidt; Andreas Dittberner; Sven Koscielny; Iver Petersen; Orlando Guntinas-Lichius
Journal:  Head Neck       Date:  2016-09-02       Impact factor: 3.147

4.  Diagnostic Efficacy of Sentinel Lymph Node Biopsy in Early Oral Squamous Cell Carcinoma: A Meta-Analysis of 66 Studies.

Authors:  Muyuan Liu; Steven J Wang; Xihong Yang; Hanwei Peng
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

5.  Fluorescent Phase-Changing Perfluorocarbon Nanodroplets as Activatable Near-Infrared Probes.

Authors:  Catalina-Paula Spatarelu; Austin Van Namen; Sidhartha Jandhyala; Geoffrey P Luke
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

Review 6.  A Systematic Review of Oral Biopsies, Sample Types, and Detection Techniques Applied in Relation to Oral Cancer Detection.

Authors:  Guanghuan Yang; Luqi Wei; Benjamin K S Thong; Yuanyuan Fu; Io Hong Cheong; Zisis Kozlakidis; Xue Li; Hui Wang; Xiaoguang Li
Journal:  BioTech (Basel)       Date:  2022-03-02

Review 7.  Recent Developments of ICG-Guided Sentinel Lymph Node Mapping in Oral Cancer.

Authors:  Ji-Hoon Kim; Minhee Ku; Jaemoon Yang; Hyung Kwon Byeon
Journal:  Diagnostics (Basel)       Date:  2021-05-17

8.  Sentinel lymph node biopsy in oral cavity cancer using indocyanine green: A systematic review and meta-analysis.

Authors:  Yongfeng Chen; Qi Xiao; Weina Zou; Chengwan Xia; Hongling Yin; Yumei Pu; Yuxin Wang; Kai Zhang
Journal:  Clinics (Sao Paulo)       Date:  2021-07-16       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.